TREA

88424864 - PHARNEXT

Follow

Information

  • Trademark
  • 88424864
  • Serial Number
    88424864
  • Registration Number
    6066907
  • Filing Date
    May 10, 2019
    5 years ago
  • Registration Date
    June 02, 2020
    4 years ago
  • Transaction Date
    January 25, 2024
    5 months ago
  • Status Date
    June 02, 2020
    4 years ago
  • Published for Opposition Date
    March 17, 2020
    4 years ago
  • Location Date
    June 02, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    REED, MAUREEN J
  • Attorney Docket Number
    CLV 0631 US
    Attorney Name
    Carlynn Ferguson Davis
    Law Office Assigned Location Code
    M60
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
PHARNEXT
Case File Statements
  • GS0411: training services in the fields of health, pharmaceutical and medical research, pharmaceutical and medical development; publication of books and texts other than publicity texts in the pharmaceutical, medical and health fields; educational services, namely, arranging and conducting educational colloquiums, conferences, congresses, and seminars in the fields of pharmaceuticals, medical and health; teaching in the pharmaceutical, medical and health fields
  • GS0051: Medicine, namely, medicines for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; pharmaceutical products for human use for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; pharmaceutical preparations for human or veterinary use for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; biological preparations for medical purposes for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; diagnostic preparations for medical diagnosis purposes; chemical preparations for medical purposes, namely, for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; food supplements and nutritional supplements for medical purposes; dietetic foods and beverages adapted for medical and pharmaceutical purposes; homeopathic and phyto-therapeutic supplements; disinfectants for hygiene purposes for medicine; bath preparations for medical purposes; dietetic beverages adapted for medical purposes; chemical reagents for medical use, namely, biomarkers; products for personal hygiene for medical purposes, namely, medical soaps; plasters and gauze for dressings for medical purposes; medical dressings, except instruments
  • GS0351: Creation, compilation and management of databases and central data files in the field of pharmaceutical research and development, medicine, genetics and clinical trials; compilation of statistics in the field of health and medicine; collection and systematization of data in a central file in the field of pharmaceutical research and development, health and medicine; public relations in the field of health and medicine
  • GS0441: medical services; pharmaceutical advice services; pharmacy consultation; medical advisory and information services relating to pharmaceutical products; medical information services; provision of medical information; providing health information services on the treatment of diseases through an awareness program
  • GS0421: pharmaceutical products development; pharmaceutical research and development; conducting tests on pharmaceutical products; conducting clinical trials for pharmaceutical products for others; scientific research in the field of medicine; bioinformatics, chemical and biological analysis; scientific research in chemistry, cosmetology, biology, bacteriology, nutrition, biotechnology; biological research and bioinformatics services in the field of chemical, biological and pharmaceutical products; software development and design in the field of pharmaceutical research, health and medicine; provision of scientific information relating to pharmaceutical products and medical and scientific research in the field of pharmaceuticals products and clinical trials; scientific research on chemical reagents for medical use, namely, biomarkers; pharmaceutical research services
Case File Event Statements
  • 6/23/2022 - 2 years ago
    24 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 1/12/2022 - 2 years ago
    23 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 6/2/2020 - 4 years ago
    22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/17/2020 - 4 years ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/17/2020 - 4 years ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/26/2020 - 4 years ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/12/2020 - 4 years ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/12/2020 - 4 years ago
    17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/12/2020 - 4 years ago
    16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 2/12/2020 - 4 years ago
    15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 2/12/2020 - 4 years ago
    14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 2/4/2020 - 4 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/4/2020 - 4 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/3/2020 - 4 years ago
    11 - ASSIGNED TO LIE Type: ALIE
  • 1/29/2020 - 4 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/1/2019 - 4 years ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/1/2019 - 4 years ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/1/2019 - 4 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/25/2019 - 4 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/25/2019 - 5 years ago
    5 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/25/2019 - 5 years ago
    4 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 5/22/2019 - 5 years ago
    3 - ASSIGNED TO LIE Type: ALIE
  • 5/15/2019 - 5 years ago
    2 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 5/14/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP